Immune-mediated membranous nephropathy: Long term fluconazole usage caused podocyte autophagy

Lan Huang1, Ya-Juan Zhao1, Qiao-Rong Dong1

  • 1Division of Nephrology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.

Insights

Membranous nephropathy (MN) can lead to serious complications. This study identifies fluconazole, an antifungal drug, as a potential cause of MN, possibly by affecting podocyte autophagy.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Membranous nephropathy (MN) is a kidney disease often causing nephrotic syndrome, increased infection risk, and high thromboembolic events.
  • MN can be idiopathic (primary) or secondary to conditions like hepatitis B, lupus, malignancy, or drug side effects.
  • Immunological responses in MN involve IgG, antigens, and complement activation (C5b-9). IgG4 is typical in idiopathic MN, while IgG1-3 dominate secondary forms.

Purpose of the Study:

  • To report a case of membranous nephropathy (MN) potentially induced by fluconazole therapy.
  • To investigate the possible mechanism of fluconazole-induced MN, focusing on podocyte autophagy.

Main Methods:

  • Case report detailing the development of MN in a patient undergoing fluconazole treatment.
  • Review of immunological markers and kidney pathology associated with MN.
  • Exploration of fluconazole's potential impact on podocyte autophagy.

Main Results:

  • A patient developed membranous nephropathy (MN) during fluconazole therapy.
  • Fluconazole, generally considered safe for kidneys, was implicated as the cause of MN.
  • The findings suggest fluconazole may potentiate podocyte autophagy, contributing to MN development.

Conclusions:

  • Fluconazole therapy can be a potential cause of membranous nephropathy (MN).
  • This case highlights a novel association between fluconazole and MN, possibly mediated by podocyte autophagy.
  • Further research is needed to confirm this link and elucidate the underlying mechanisms.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
178
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
96
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
406
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
286
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
75.5K